SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology Value Fund, L.P.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LLCF who wrote (587)4/8/1999 11:47:00 PM
From: scaram(o)ucheRead Replies (1) of 4974
 
>> PS... are you saying this compound is still "unpartnered"? <<

Gary Lyons isn't messing around. If thread participants don't have a
feel for a given management team, just ask.

- ------------------------------------------------------------------------------------------------------------------------
Program Indication Status Commercial Rights
- ------- ---------- ------ -----------------
<S> <C> <C> <C>
CRF Receptor Antagonist Anxiety/Depression Phase II Janssen/Neurocrine
Altered Peptide Ligand Multiple Sclerosis Phase II Novartis/Neurocrine
IL-4 Fusion Toxin Glioblastoma Phase I/II Neurocrine
GABA Receptor Subtype Agonist Insomnia Phase I/II Neurocrine
Altered Peptide Ligand Type I diabetes Phase I Neurocrine

CRF Receptor Antagonist Stroke Development Neurocrine
CRF / Urocortin Agonist Alzheimer's/Obesity Research Lilly/Neurocrine
Excitatory Amino Acid Transporters Stroke Research Wyeth-Ayerst/Neurocrine
Melanocortin Receptor Antagonist Obesity Research Neurocrine
Chemokine Antagonist Inflammatory Disorders Research Neurocrine
GNRh Endometriosis Research Neurocrine
Neurogenomics Neurodegenerative Research NPI/Neurocrine
- ------------------------------------------------------------------------------------------------------------------------
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext